Shiloh
Editor, Senior Moderator
Source: https://muhc.ca/newsroom/news/latent-tb-treatment-shorter-better
Latent TB Treatment: Shorter is Better
Game-changing study on treatment of latent Tuberculosis shows a novel, short therapy is safer and more effective in children and adults than standard therapy
Aug 1, 2018
Montreal ? Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more effective in children and adults compared to the current standard. These findings are published today in the New England Journal of Medicine.
Led by Dr. Dick Menzies, the study followed 850 children and 6,800 adults with latent TB, a dormant version of the disease that does not cause symptoms but may lead to serious illness if treatment is not provided. This study in children is one of the largest for a pediatric clinical trial related to TB...
Latent TB Treatment: Shorter is Better
Game-changing study on treatment of latent Tuberculosis shows a novel, short therapy is safer and more effective in children and adults than standard therapy
Aug 1, 2018
Montreal ? Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more effective in children and adults compared to the current standard. These findings are published today in the New England Journal of Medicine.
Led by Dr. Dick Menzies, the study followed 850 children and 6,800 adults with latent TB, a dormant version of the disease that does not cause symptoms but may lead to serious illness if treatment is not provided. This study in children is one of the largest for a pediatric clinical trial related to TB...